In The News,
ADVI’s Lindsay Bealor Greenleaf Discusses President Trump’s Drug Pricing Plan with The Street
[el-text]
Written by Bill Meagher
***excerpt***
Lindsay Bealor Greenleaf, a director at ADVI, a healthcare and life science advisory, praised the Trump administration for wanting to take on the middlemen and being “willing to get down into the weeds on this.” She said that the Obama administration wanted to point the finger at drug companies, but Trump is willing to wade into the supply chain, that she called “messy and complicated.”
***end excerpt***
***
[/el-text]